BIONTECH SE Products & Brands - Key Offerings and Insights

Products

Category

Product

Brand

Description

Global Pharmaceutical Drugs Industry: Competitive Landscape 2023 (PHM263B)

Comirnaty (BNT162b2)		An mRNA-based COVID-19 vaccine developed in partnership with Pfizer. It protects SARS-CoV-2 by instructing cells to produce a spike protein that triggers an immune response. Approved globally, it has been a key tool in managing the pandemic.
Comirnaty XBB.1.5		It is an updated COVID-19 vaccine designed to target the Omicron XBB.1.5 variant. It enhances immunity against newer strains and is approved for booster doses in several countries.

This information is available for BCC Research members only.

Already a Member? Sign In Become a Member

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.